| Literature DB >> 17976996 |
Emilie D Smith1, N Ariane Vinson, Desong Zhong, Bertold D Berrang, Jennifer L Catanzaro, James B Thomas, Hernán A Navarro, Brian P Gilmour, Jeffrey Deschamps, F Ivy Carroll.
Abstract
A new chiral synthesis of the ORL-1 antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (2, J-113397) was developed. J-113397 has a K(e)=0.85nM in an ORL-1 calcium mobilization assay and is 89-, 887-, and 227-fold selective for the ORL-1 receptor relative to the mu, delta, and kappa opioid receptors.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17976996 PMCID: PMC2323199 DOI: 10.1016/j.bmc.2007.10.023
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641